Company Profile
PharmaVision was created by Dr Cheryl Lee Barton in 2002 to provide independent, tailor made pharmaceutical thematic research to investment houses, competitive intelligence specialists and pharmaceutical companies. The research reports combine independent scientific analysis with market models to forecast the potential growth of key developmental products and technologies.
Pharmavision was formed in order to write and publish independent and impartial analysis of the pharmaceutical industry with a focus on drug delivery, it’s players, their products and the issues surrounding this specialist sector. Using PharmaVision's market modeling and analysis insight, we aim to deliver market analysis papers of quality and value to its readers.
Latest Papers
Novel Antibodies & Therapeutic Proteins:Technological Challenges & Future Prospects From the 1990s onwards, growing insight into the biological processes responsible for disease led to a drive to develop treatments based on the biological contributors to in disease processes – for example, antibodies to inactivate disease-causing an... Price: £995.00 Author: Dr Cheryl L Barton / Date Published: 04 August 2010 |
Advances in Imaging Biomarkers:Innovative technologies, applications in R&D and clinical practice, and informatics and regulatory requirements Imaging biomarkers, those quantified using imaging modalities including Magnetic Resonance Imaging and Positron Emission Tomography, are attractive for a variety of reasons: the methods of measurement used are non-invasive, and can provide informatio... Price: £2,570.00 Author: Dr Cheryl L Barton & Dr Sara Sleigh / Date Published: 12 July 2010 |
Biotech for WellnessDriving successful R&D and licensing in nutraceuticals The biotech and nutraceutical industries are targeting some of the same lifestyle disease growth markets, but from a different standpoint and with different goals. Consequently, a number of factors are leading to the convergence of the food and biote... Price: £3,214.00 Author: Dr Cheryl L Barton / Date Published: 30 April 2010 |



Novel Antibodies & Therapeutic Proteins: